المؤلفون: Ivan Balabolkin I., Vilya Bulgakova A., Vsevolod Pinelis G., Elena Tyumentseva S., И. Балаболкин И., В. Булгакова А., В. Пинелис Г., Е. Тюменцева С.

المساهمون: ФГАУ ННПЦЗД Минздрава России, комплексная тема № 01201156060

المصدر: Bulletin of Siberian Medicine; Том 16, № 2 (2017); 20-31 ; Бюллетень сибирской медицины; Том 16, № 2 (2017); 20-31 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2017-16-2

مصطلحات موضوعية: bronchial asthma, genotype, polymorphism, β2 -adrenoreceptor, glucocorticoid receptors, 5-lipoxygenase, Cys-LT (cysteinyl leukotriene), variability therapeutic response, бронхиальная астма, генотип, полиморфизм, β2-адренорецепторы, глюкокортикоидные рецепторы, 5-липооксигеназа, Cys-LT (цистеинил-лейкотриены), вариабельность терапевтического ответа

وصف الملف: application/pdf

العلاقة: https://bulletin.tomsk.ru/jour/article/view/873/675Test; Muraro A., Lemanske R.F.Jr., Hellings P.W., Akdis C.A., Bieber T., Casale T.B., Jutel M., Ong P.Y., Poulsen L.K., Schmid-Grendelmeier P., Simon H.U., Seys S.F., Agache I. Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology // J. Allergy Clin. Immunol. 2016; 137 (5): 1347–1358. DOI:10.1016/j.jaci.2016.03.010.; Agache I., Akdis C., Jutel M., Virchow J.C. Untangling asthma phenotypes and endotypes // Allergy. 2012; 67 (7): 835–846. DOI:10.1111/j.1398-9995.2012.02832.x.; Wenzel S.E. Asthma phenotypes: the evolution from clinical to molecular approaches // Nat. Med. 2012; 18 (5): 716–725. DOI:10.1038/nm.2678.; Lötvall J., Akdis C.A., Bacharier L.B., Bjermer L., Casale T.B., Custovic A. et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome // J. Allergy Clin Immunol. 2011; 127 (2): 355–360. DOI:10.1016/j.jaci.2010.11.037.; Moffatt M.F., Kabesch M., Liang L., Dixon A.L., Strachan D., Heath S., Depner M., von Berg A., Bufe A., Rietschel E. et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma // Nature. 2007; 448 (7152): 470–473. DOI:10.1038/nature06014.; March M.E., Sleiman P.M., Hakonarson H. The genetics of asthma and allergic disorders // Discov Med. 2011; 11 (56): 35–45.; Miller S.M., Ortega V.E. Pharmacogenetics and the development of personalized approaches for combination therapy in asthma // Curr. Allergy Asthma Rep. 2013; 13 (5): 443–452. DOI:10.1007/s11882-013-0372-x.; Evans W., McLeod H.L. Pharmacogenomics-drug disposition, drug targets, and side effects // N. Engl. J. Med. 2003; 348 (6): 538–549. DOI:10.1056/NEJMra020526.; Ortega V.E., Meyers D.A., Bleecker E.R. Asthma pharmacogenetics and the development of genetic profiles for personalized medicine // Pharmgenomics Pers. Med. 2015; 8: 9–22. DOI:10.2147/PGPM.S52846. eCollection 2015.; Кукес В.Г., Олефир В.Р., Прокофьев А.Б., Ших Е.В., Маринин В.Ф., Раменская Г.В., Хохлов А.Л., Журавлева М.В., Демченкова Е.Ю., Жестовская А.С., Руднев С.Г., Сычев Д.А., Румянцев Н.А., Александрова Т.В. Развитие персонализированной медицины в Рос- сии: взгляд клинического фармаколога // Клиническая фармакология и терапия. 2016; 25 (5): 14–17.; Drazen J.M., Silverman E.K., Lee T.H. Heterogeneity of therapeutic responses in asthma // Br. Med. Bull. 2000; 56 (4): 1054–1570.; Silverman E.S., Liggett S.B., Gelfand E.W., Rosenwasser L.J., Baron R.M., Bolk S., Weiss S.T. and Drazen J.M. The pharmacogenetics of asthma: a candidate gene approach // The Pharmacogenomics J. 2001; 1 (1): 27–37.; Tse S.M., Tantisira K., Weiss S.T. The pharmacogenetics and pharmacogenomics of asthma therapy // Pharmacogenomics J. 2011; 11 (6): 383–392. DOI:10.1038/ tpj.2011.46.; Barnes P.J. Glucocorticoids // Chem. Immunol. Allergy. 2014; 100: 3116. DOI:10.1159/000359984. Epub 2014 May 22.; Балаболкин И.И., Булгакова В.А. Бронхиальная астма у детей. М.: Медицинское информационное агентство, 2015: 144.; van Rossum E.F., van den Akker E.L. Glucocorticoid resistance // Endocr. Dev. 2011; 20: 127–136. DOI:10.1159/000321234.; Panek M., Pietras T., Fabijan A., Miłanowski M., Wieteska L., Górski P., Kuna P., Szemraj J. Effect of glucocorticoid receptor gene polymorphisms on asthma phenotypes // Exp. Ther. Med. 2013; 5 (2): 572–580. DOI:10.3892/etm.2012.809.; Pietras T.I., Panek M., Tworek D., Oszajca K., Wujcik R., Górski P., Kuna P., Szemraj J. The Bcl I single nucleotide polymorphism of the human glucocorticoid receptor gene h-GR/NR3C1 promoter in patients with bronchial asthma: pilot study // Mol. Biol. Rep. 2011; 38 (6): 3953–3958. DOI:10.1007/s11033-010-0512-5.; Cuzzoni E.I., de Iudicibus S., Bartoli F., Ventura A., Decorti G. Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone // Br. J. Clin. Pharmacol. 2012; 73 (4): 651–655. DOI:10.1111/j.1365- 2125.2011.04130.x.; Жданова М.В., Богданова М.А., Войтович А.Н., Ащепкова О.М., Журавская Е.Э., Трофимова Н.В., Но- вик Г.А., Ларионова В.И. Особенности течения бронхиальной астмы у детей с различными генотипами BclI полиморфизма гена глюкокортикоидного рецептора // Педиатрия им. Г.Н. Сперанского. 2007; 86 (4): 19–24.; DeRijk R.H.I., Schaaf M., de Kloet E.R. Glucocorticoid receptor variants: clinical implications // J. Steroid Biochem. Mol. Biol. 2002; 81 (2): 103–122.; Тюменцева Е.С. Структура и взаимодействие наслед- ственных факторов предрасположенности к разви- тию атопических болезней у детей // Российский педиатрический журнал. 2011; 5: 24–28.; Szefler S.J., Martin R.J., King T.S., Boushey H.A., Cherniack R.M., Chinchilli V.M., Craig T.J., Dolovich M., Drazen J.M., Fagan J.K., Fahy J.V., Fish J.E., Ford J.G., Israel E., Kiley J., Kraft M., Lazarus S.C., Lemanske R.F. Jr., Mauger E., Peters S.P., Sorkness C.A. Asthma Clinical Research Network of the National Heart Lung, and Blood Institute. Significant variability in response to inhaled corticosteroids for persistent asthma // J. Allergy Clin Immunol. 2002; 109 (3): 410–418.; Adcock I.M., Ford P.A., Bhavsar P., Ahmad T., Chung K.F. Steroid resistance in asthma: mechanisms and treatment options // Curr. Allergy Asthma Rep. 2008; 8 (2): 171–178.; Barnes P.J. Corticosteroid resistance in airway disease // Proc. Am. Thorac. Soc. 2004; 1 (3): 264–268. DOI:10.1513/pats.200402-014MS. 26. Stevens A., Ray D.W., Zeggini E., John S., Richards H.L., Griffiths C.E. M., Donn R. Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype // J. Clin. Endocrinol. Metab. 2004; 89 (2): 892–897.; Tantisira K.G., Silverman E.S., Mariani T.J., Xu J., Richter B.G., Klanderman B.J., Litonjua A.A., Lazarus R., Rosenwasser L.J., Fuhlbrigge A.L., Weiss S.T. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma // J. Allergy Clin Immunol. 2007; 120 (6): 1285–1291. DOI:10.1016/j.jaci.2007.09.005.; Tantisira K.G., Lake S., Silverman E.S., Palmer L.J., Lazarus R., Silverman E.K., Liggett S.B., Gelfand E.W., Rosenwasser L.J., Richter B., Israel E., Wechsler M., Gabriel S., Altshuler D., Lander E., Drazen J., Weiss S.T. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids // Hum. Mol. Genet. 2004; 13 (13): 1353–1359. DOI:10.1093/hmg/ddh149.; Tantisira K.G., Lazarus R., Litonjua A.A., Klanderman B., Weiss S.T. Chromosome 17: association of a large inversion polymorphism with corticosteroid response in asthma // Pharmacogenet. Genomics. 2008; 18 (8): 733– 737. DOI:10.1097/FPC.0b013e3282fe6ebf.; Hakonarson H., Bjornsdottir U.S., Halapi E., Bradfield J., Zink F., Mouy M., Helgadottir H., Gudmundsdottir A.S., Andrason H., Adalsteinsdottir A.E., Kristjansson K., Birkisson I., Arnason T., Andresdottir M., Gislason D., Gislason T., Gulcher J.R., Stefansson K. Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients // Proc. Nat. Acad. Sci. USA. 2005; 102 (41): 14789–14794. DOI:10.1073/pnas.0409904102.; Балаболкин И.И., Брянцева О.Н., Тихомиров Е.Е., Пинелис В.Г., Журкова Н.В., Тюменцева Е.Е., Баязутди- нова Г.М., Аверьянова Н.С. Генетические маркеры ýффективности бронхоспазмолитической терапии детей, страдающих атопической бронхиальной астмой // Иммунопатология, аллергология, инфектология. 2008; 2: 53–58.; Васьковский Н.В., Огородова Л.М., Фрейдин М.Б., Серебров В.Ю., Петровский Ф.И., Деев И.А. Роль полиморфизма гена β2 -адренергического рецептора в развитии бронхиальной астмы // Медицинская генетика. 2006; 1: 10–14.; Green S.A., Turki J., Innis M. and Liggett S.B. Amino-terminal polymorphisms of the human β2 -adrenergic receptor impart distinct agonist-promoted regulatory properties // Biochemistry. 1994; 33 (32): 9414–9419.; Turner S.W., Khoo S.K., Laing I.A., Palmer L.J., Gibson N.A., Rye P., Landau L.I., Goldblatt J., le Souëf P.N. β2 -adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and asthma in infants and children // Clin. Exp. Allergy. 2004; 34 (7): 1043–1048. DOI:10.1111/j.1365-2222.2004.02001.x.; Finkelstein Y., Bournissen F.G., Hutson J.R., Shannon M. Polymorphism of the ADRB2 gene and response to inhaled beta-agonists in children with asthma: a meta-analysis // J. Asthma. 2009; 46 (9): 900–905. DOI:10.3109/02770900903199961.; Martinez F.D., Graves P.E., Baldini M., Solomon S., Erickson R. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing // J. Clin. Invest. 1997; 100 (12): 3184–3188. DOI:10.1172/ JCI119874.; Брянцева О.Н., Тихомиров Е.Е., Журкова Н.В., Вознесенская Н.И., Баязутдинова Г.М., Аверьянова Н.С., Балаболкин И.И., Пинелис В.Г. Полиморфизм гена β2 - адренергического рецептора и ýффективность бронхо- литической терапии у детей с бронхиальной астмой // Педиатрическая фармакология. 2007; 4 (3): 35–39.; Wechsler M.E., Lehman E., Lazarus S.C., Lemanske R.F. Jr., Boushey H.A., Deykin A., Fahy J.V., Sorkness C.A., Chinchilli V.M., Craig T.J., DiMango E., Kraft M., Leone F., Martin R.J., Peters S.P., Szefler S.J., Liu W., Israel E. National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network. Beta-Adrenergic receptor polymorphisms and response to salmeterol // Am. J. Respir. Crit. Care Med. 2006; 173 (5): 519–526.; Pillai S.G., Chiano M.N., White N.J., Speer M., Barnes K.C., Carlsen K., Gerritsen J., Helms P., Lenney W., Silverman M., Sly P., Sundy J., Tsanakas J., von Berg A., Whyte M., Varsani S., Skelding P., Hauser M., Vance J., Pericak-Vance M., Burns D.K., Middleton L.T., Brewster S.R., Anderson W.H., Riley J.H. A genome-wide search for linkage to asthma phenotypes in the genetics of asthma international network families: evidence for a major susceptibility locus on chromosome 2p // Eur. J. Hum. Genet. 2006; 14 (3): 307–316. Erratum in: Eur J Hum Genet. 2007; 15 (6): 714. DOI:10.1038/sj.ejhg.5201532.; Балаболкин И.И., Тюменцева Е.С. Генетика атопи- ческих болезней у детей // Вестник Российской академии медицинских наук. 2010; 4: 15–22.; Mashima R., Okuyama T. The role of lipoxygenases in pathophysiology; new insights and future perspectives // Redox Biol. 2015; 6: 297–310. DOI:10.1016/j.redox.2015.08.006.; In K.H., Silverman E.S., Asano K., Beier D., Fischer A.R., Keith T.P., Serino K., Yandava C., de Sanctis G.T., Drazen J.M. Mutations in the human 5-lipoxygenase gene // Clin. Rev. Allergy Immunol. 1999; 17 (1–2): 59-69. DOI:10.1007/BF02737597.; Scadding G.W., Scadding G.K. Recent advances in antileukotriene therapy // Curr. Opin. Allergy Clin. Immunol. 2010; 10 (4): 370–376. DOI:10.1097/ACI.0b013e32833bfa20.; Muijsers R.B., Noble S. Montelukast: a review of its therapeutic potential in asthma in children 2 to 14 years of age // Paediatr Drugs. 2002; 4 (2): 123–139. DOI:10.2165/00128072-200204020-00005.; Ghiro L., Zanconato S., Rampon O., Piovan V., Pasquale M.F., Baraldi E. Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children // Eur. Respir J. 2002; 20 (3): 630–634.; Knorr B., Matz J., Bernstein J.A., Nguyen H., Seidenberg B.C., Reiss T.F., Becker A. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group // JAMA. 1998; 279 (15): 1181–1186.; Knorr B., Franchi L.M., Bisgaard H., Vermeulen J.H., LeSouef P., Santanello N., Michele T.M., Reiss T.F., Nguyen H.H., Bratton D.L. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years // Pediatrics. 2001; 108 (3): E48.; Bisgaard H., Zielen S., Garcia-Garcia M.L., Johnston S.L., Gilles L., Menten J., Tozzi C.A., Polos P. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma // Am. J. Respir. Crit. Care Med. 2005; 171 (4): 315–322. DOI:10.1164/rccm.200407-894OC.; Балаболкин И.И., Смирнов И.Е., Ляпунов А.В. Луки- на О.Ф., Горюнов А.В., Гончарова Н.В., Реутова B.C. Эффективность лечения монтелукастом детей с брон- хиальной астмой // Вопросы современной педиатрии. 2006; 5 (5): 35–38.; Drazen J.M., Yandava C.N., Dubé L., Szczerback N., Hippensteel R., Pillari A., Israel E., Schork N., Silverman E.S., Katz D.A., Drajesk J. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment // Nat. Genet. 1999; 22 (2): 168–170. DOI:10.1038/9680.; Lima J.J., Zhang S., Grant A., Shao L., Tantisira K.G., Allayee H., Wang J., Sylvester J., Holbrook J., Wise R., Weiss S.T., Barnes K. Influence of leukotriene pathway polymorphisms on response to montelukast in asthma // Am. J. Respir. Crit. Care Med. 2006; 173 (4): 379–385. DOI:10.1164/rccm.200509-1412OC.; Telleria J.J., Blanco-Quiros A., Varillas D., Armentia A., Fernandez-Carvajal I., Jesus Alonso M., Diez I. ALOX5 promoter genotype and response to montelukast in moderate persistent asthma // Respir. Med. 2008; 102 (6): 857–861. DOI:10.1016/j.rmed.2008.01.011.; Mougey E.B., Lang J.E., Wen X., Lima J.J. Effect of citrus juice and SLCO2B1 genotype on the pharmacokinetics of montelukast // J. Clin. Pharmacol. 2011; 51 (5): 751–760. doi:10.1177/0091270010374472.; Makeeva O.A., Markova V.V., Roses A.D., Puzyrev V.P. An epidemiologic-based survey of public attitudes towards predictive genetic testing in Russia // Personalized Medicine. 2010; 7 (3): 291–300. DOI 10.2217/ pme.10.23.; Stallings S.C., Huse D., Finkelstein S.N., Crown W.H., Witt W.P., Maguire J., Hiller A.J., Sinskey A.J., Ginsburg G.S. A framework to evaluate the economic impact of pharmacogenomics // Pharmacogenomics. 2006; 7 (6): 853–862. DOI:10.2217/14622416.7.6.853.; https://bulletin.tomsk.ru/jour/article/view/873Test

الإتاحة: https://doi.org/10.20538/1682-0363-2017-2-20-31Test
https://doi.org/10.20538/1682-0363-2017-16-2Test
https://doi.org/10.1111/j.1398-9995.2012.02832.xTest
https://doi.org/10.1038/nm.2678Test
https://doi.org/10.1016/j.jaci.2010.11.037Test
https://doi.org/10.1038/nature06014Test
https://doi.org/10.1007/s11882-013-0372-xTest
https://doi.org/10.1056/NEJMra020526Test
https://doi.org/10.2147/PGPM.S52846Test
https://doi.org/10.1159/000359984Test

المؤلفون: Seyyed Shamsadin Athari, Minmin Huang, Entezar Mehrabi Nasab

المصدر: Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences, Vol 28, Iss 12, Pp 6957-6962 (2021)

مصطلحات موضوعية: OPA1, Mitochondrial dynamin like GTPase, Allergy, AHR, Airway hyperresponsiveness, IT, Intratrachea administration, MFN, Mitofusin, Cytb, Cytochrome b, MSC, mesenchymal stem cell, Mitochondrion, Ig, Immunoglobulin, PGE2, Prostaglandin E2, IP, Intraperitoneal injection, MSC/IV, mesenchymal stem cell intravenous injection, MSC/BI, mesenchymal stem cell bronchial administration, IL, Interleukin, Biology (General), PGC1a, Peroxisome proliferator-activated receptor gamma coactivator 1-alpha, BM, Bone marrow, H&E, Haemotoxylin and eosin, OVA, Ovalbumin, FIS1, Mitochondrial fission 1 protein, Cys-LT, Cysteinyl Leukotriene, respiratory system, TGF, Transforming growth factor, PBS, Phosphate-buffered saline, IFN, Interferon, HLA, Human leukocyte antigen, medicine.anatomical_structure, ELISA, Enzyme-linked immunosorbent assay, Original Article, ATP, Adenosine triphosphate, medicine.symptom, Signal transduction, CD, Cluster of differentiation, General Agricultural and Biological Sciences, MIP, macrophage inflammatory protein, PAS, Periodic-acid-Schiff, MMP, Matrix metalloproteinase, TFAM, Transcription factor A mitochondrial, QH301-705.5, Inflammation, COX, Cyclooxygenase, NO, Nitric oxide, MSC, iPSC, induced pluripotent stem cells, Nrf, Nuclear erythroid 2 p45-related factor, CCL, Chemokine (C-C motif) ligand, medicine, BALF, Bronchoalveolar lavage fluid, LT, Leukotriene, Th, T helper, Asthma, ComputingMethodologies_COMPUTERGRAPHICS, Goblet cell, Drp1, Mitochondrial fission depends on the cytosolic GTPase dynamin-related protein 1, business.industry, Mesenchymal stem cell, TNF, Tumor necrosis factor, Eosinophil, HGF, Hepatocyte growth factor, medicine.disease, Mucus, respiratory tract diseases, HO, Heme oxygenase, Immune system, IDO, Indoleamine 2,3-dioxygenase, Immunology, business, ND1, NADH-ubiquinone oxidoreductase chain 1, ROS, Reactive oxygen species

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06d570e737062499ca4ded98c542acd9Test
https://pubmed.ncbi.nlm.nih.gov/34866995Test

المؤلفون: Toshihide Suzuki, Tomohiro Rogi, Hiroshi Kawashima, Kayo Saito, Kahori Egawa, Hiroshi Shibata, Satoshi Sasaki, Saki Kakutani, Chika Horikawa

المصدر: Journal of Nutritional Science

مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, Nutrition and Dietetics, Epidemiology, business.industry, Quality assessment, Endocrinology, Diabetes and Metabolism, Free-living populations, Strengthening the reporting of observational studies in epidemiology, medicine.disease, Asthma, Review – Systematic, Arachidonic acid intake, Dietary fatty acids, Cysteinyl leukotrienes, ARA, arachidonic acid, medicine, STROBE, Strengthening the Reporting of Observational Studies in Epidemiology, Observational study, business, Methodological quality, cys-LT, cysteinyl leukotriene, Food Science

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505dcaafd625b7b87cfcf415dfd7745aTest
https://doi.org/10.1017/jns.2014.9Test